Cargando…

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects. The physiological response to oral ingestion of nutrients, involving the incretin system, is reduced...

Descripción completa

Detalles Bibliográficos
Autor principal: Hinnen, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556578/
https://www.ncbi.nlm.nih.gov/pubmed/28848315
http://dx.doi.org/10.2337/ds16-0026

Ejemplares similares